AU4771299A - Use of benzomorphan derivatives as an analgesic - Google Patents
Use of benzomorphan derivatives as an analgesicInfo
- Publication number
- AU4771299A AU4771299A AU47712/99A AU4771299A AU4771299A AU 4771299 A AU4771299 A AU 4771299A AU 47712/99 A AU47712/99 A AU 47712/99A AU 4771299 A AU4771299 A AU 4771299A AU 4771299 A AU4771299 A AU 4771299A
- Authority
- AU
- Australia
- Prior art keywords
- analgesic
- benzomorphan derivatives
- benzomorphan
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1998126365 DE19826365A1 (en) | 1998-06-12 | 1998-06-12 | Use of benzomorphan derivatives as an analgesic |
DE19826365 | 1998-06-12 | ||
PCT/EP1999/004020 WO1999065485A1 (en) | 1998-06-12 | 1999-06-11 | Use of benzomorphan derivatives as an analgesic |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4771299A true AU4771299A (en) | 2000-01-05 |
Family
ID=7870774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47712/99A Abandoned AU4771299A (en) | 1998-06-12 | 1999-06-11 | Use of benzomorphan derivatives as an analgesic |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1085866A1 (en) |
AU (1) | AU4771299A (en) |
DE (1) | DE19826365A1 (en) |
WO (1) | WO1999065485A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10153345A1 (en) * | 2001-10-29 | 2003-05-08 | Gruenenthal Gmbh | Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl and 4-heteroarylcyclohexane compounds |
EP2858976B1 (en) * | 2012-05-11 | 2018-03-14 | Purdue Pharma LP | Benzomorphan compounds as opioid receptors modulators |
JP6400592B2 (en) * | 2012-11-09 | 2018-10-03 | パーデュー、ファーマ、リミテッド、パートナーシップ | Benzomorphan analogs and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7804509A (en) * | 1978-04-26 | 1979-10-30 | Acf Chemiefarma Nv | Novel 6,7-benzomorphan derivatives and their acid addition salts. |
DE4121821A1 (en) * | 1991-07-02 | 1993-01-14 | Boehringer Ingelheim Kg | NEW BENZOMORPHANE AND ITS USE AS A MEDICAMENT |
DE19528472A1 (en) * | 1995-08-03 | 1997-02-06 | Boehringer Ingelheim Kg | New process for the production of norbenzomorphan of an intermediate stage in the production of pharmaceutically valuable benzomorphan derivatives, in particular of (-) - (1R, 5S, S "R) -3'-hydroxy-2- (2-methoxypropyl -) - 5.9.9 -trimethyl-6.7 benzomorphan |
DE19740110A1 (en) * | 1997-09-12 | 1999-03-18 | Boehringer Ingelheim Pharma | New hydroxy substituted benzomorphan derivatives |
-
1998
- 1998-06-12 DE DE1998126365 patent/DE19826365A1/en not_active Withdrawn
-
1999
- 1999-06-11 AU AU47712/99A patent/AU4771299A/en not_active Abandoned
- 1999-06-11 EP EP99931054A patent/EP1085866A1/en not_active Withdrawn
- 1999-06-11 WO PCT/EP1999/004020 patent/WO1999065485A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE19826365A1 (en) | 1999-12-16 |
EP1085866A1 (en) | 2001-03-28 |
WO1999065485A1 (en) | 1999-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU763356C (en) | Fused-ring compounds and use thereof as drugs | |
AU7389300A (en) | Methods of administration of glycopyrrolate compositions | |
AU3867400A (en) | Methods of using bioelastomers | |
AU4423499A (en) | Novel analgesic agents | |
AU2584399A (en) | Point of sale device | |
AU3216600A (en) | Analgesic compositions comprising anti-epileptic compounds and methods of using same | |
AU4458700A (en) | Uses of phenylglycine derivatives | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
AU5565099A (en) | Pharmaceutical compositions and methods for use | |
AU2220801A (en) | Tricyclic compounds and addition salts thereof | |
AU5161399A (en) | N-benzocycloalkyl-amide derivatives and their use as medicaments | |
AU3841499A (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents | |
AU5762099A (en) | The preparation of (n)-substituted-hydroxycycloalkylamine derivatives | |
AU2742799A (en) | Voacamine as anti-malarial agent and anti-malarial agent containing voacamine | |
AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
AU5882298A (en) | New analgesic composition | |
AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
AU4771299A (en) | Use of benzomorphan derivatives as an analgesic | |
AU1304801A (en) | Tricyclic azaindolizine derivatives having an SPLA2- inhibiting effect | |
AU3192500A (en) | Substituted proline derivatives and medicinal compositions containing the same | |
AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU4450100A (en) | 225Ac-heha and related compounds, methods of synthesis and methods of use | |
AU2880699A (en) | Pharmaceutical compositions and methods for use | |
AU5622599A (en) | Use of 5-amino-pyrazol-derivatives for combating micro-organisms | |
AU4968197A (en) | Novel phenanthridinium derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |